We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Holds Sponsors Accountable for Post-Marketing Studies
FDA Holds Sponsors Accountable for Post-Marketing Studies
FDA Commissioner Scott Gottlieb said the agency is committed to ensuring “timely completion” of post-marketing studies by drug sponsors in a statement about the agency’s latest report on the status of reviews.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor